Stockreport

Zoetis Cuts Guidance As Librela Safety Questions Test Growth Story [Yahoo! Finance]

Zoetis Inc. Class A  (ZTS) 
Last zoetis inc. class a earnings: 2/13 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.zoetis.com
PDF Zoetis (NYSE:ZTS) reduced its full year guidance after raising safety concerns around its osteoarthritis drug Librela. Management said it intends to address questions [Read more]